Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (781-790 of 4,265) with videos related to

Pageof 427
Sort By:
Cancer Discovery|January 8, 2017
Mixed Results for Sunitinib in Renal Cancer
Cancer Discovery|February 1, 2017
Cancer Death Rate Down 25% Since 1991
Cancer Discovery|February 4, 2017
Global Cost of Smoking Passes $1 Trillion
Cancer Discovery|January 11, 2017
The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell LymphomaJiyuan Zhang, Sofija Vlasevska, Victoria A Wells, et al.
Cancer Discovery|January 11, 2017
Anti-CD22 CAR Therapy Leads to ALL Remissions
Cancer Discovery|December 1, 2016
Tapping Big Data to Help Little Patients
Cancer Discovery|January 28, 2017
NCI Launches Drug Formulary
Cancer Discovery|November 20, 2016
Pinpointing Cancer Stem Cells in Oligodendroglioma
Cancer Discovery|November 20, 2016
IFNγ Mutations Prompt CTLA-4 Inhibitor Resistance
Cancer Discovery|October 13, 2016
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E MutationDavid S Hong, Van K Morris, Badi El Osta, et al.
Pageof 427

Showing results (781-790 of 4,265) with videos related to

Sort By:
Pageof 427
Cancer Discovery|January 8, 2017
Mixed Results for Sunitinib in Renal Cancer
Cancer Discovery|February 1, 2017
Cancer Death Rate Down 25% Since 1991
Cancer Discovery|February 4, 2017
Global Cost of Smoking Passes $1 Trillion
Cancer Discovery|January 11, 2017
The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell LymphomaJiyuan Zhang, Sofija Vlasevska, Victoria A Wells, et al.
Cancer Discovery|January 11, 2017
Anti-CD22 CAR Therapy Leads to ALL Remissions
Cancer Discovery|December 1, 2016
Tapping Big Data to Help Little Patients
Cancer Discovery|January 28, 2017
NCI Launches Drug Formulary
Cancer Discovery|November 20, 2016
Pinpointing Cancer Stem Cells in Oligodendroglioma
Cancer Discovery|November 20, 2016
IFNγ Mutations Prompt CTLA-4 Inhibitor Resistance
Cancer Discovery|October 13, 2016
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E MutationDavid S Hong, Van K Morris, Badi El Osta, et al.
Pageof 427